Synovium to Myocardium: A Case of Calcium Pyrophosphate Dihydrate Crystal Arthritis Associated With Myocardial Infarction

被引:0
作者
Raza, Mahanoor [1 ]
Rana, Masooma S. [2 ]
Arif, Mobeena [1 ]
Akinpelu, Taofeek [3 ]
Waheed, Abdul [1 ,4 ]
机构
[1] WellSpan Good Samaritan Hosp, Family Med, Lebanon, NH 17042 USA
[2] Aga Khan Univ Hosp, Family Med, Karachi, Pakistan
[3] WellSpan Good Samaritan Hosp, Family Med Residency Program, Lebanon, NH USA
[4] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Family & Community Med, Hershey, PA 17033 USA
关键词
calcium pyrophosphate dihydrate crystal deposition; cppd arthritis; myocardial infarction; crystal arthropathy; pseudogout; CARDIOVASCULAR-DISEASE; RISK; CALCIFICATION;
D O I
10.7759/cureus.34528
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Both gout and pseudogout are crystal-induced arthropathies. Here, we report a case of acute calcium pyrophosphate dihydrate (CPPD) arthritis associated with type 1 myocardial infarction (MI). An 83-year-old female presented to our emergency department with generalized weakness and bilateral lower extremity edema. Her left foot was noted to be more inflamed compared to the right, with cardinal signs of pain, swelling, erythema, and warmth. A presumptive diagnosis of cellulitis was made, and antibiotics were initiated. Further investigations revealed elevated troponins with new-onset bundle branch block, ST, and T -wave changes on electrocardiogram, indicating a type 1 MI. After a review of the patient's history, imaging of the extremity, elevated inflammatory markers, and the typical distribution and pattern of inflammation, the diagnosis was changed to pseudogout. Steroids and colchicine were initiated, providing instant relief. This case highlights a possible association between cardiovascular disease and pseudogout, emphasizing the need for further studies regarding this relationship. Despite being rare, physicians should be made aware of this relationship, especially in patients with a history of CPPD arthritis presenting with type 1 MI.
引用
收藏
页数:6
相关论文
共 20 条
[11]   Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study [J].
Ogdie, Alexis ;
Yu, YiDing ;
Haynes, Kevin ;
Love, Thorvardur Jon ;
Maliha, Samantha ;
Jiang, Yihui ;
Troxel, Andrea B. ;
Hennessy, Sean ;
Kimmel, Steven E. ;
Margolis, David J. ;
Choi, Hyon ;
Mehta, Nehal N. ;
Gelfand, Joel M. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) :326-332
[12]  
Parperis K, 2022, ARTHRITIS RHEUMATOL, V74, P3594
[13]   Outcomes and resource utilization in calcium pyrophosphate deposition disease patients who underwent total knee arthroplasty: a cross-sectional analysis [J].
Parperis, Konstantinos ;
Hadi, Mohanad ;
Bhattarai, Bikash .
CLINICAL RHEUMATOLOGY, 2022, 41 (06) :1817-1824
[14]   Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: A prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms [J].
Pego-Reigosa, JM ;
Rodriguez-Rodriguez, M ;
Hurtado-Hernandez, Z ;
Gromaz-Martin, J ;
Taboas-Rodriguez, D ;
Millan-Cachinero, C ;
Hernandez-Rodriguez, I ;
Gonzalez-Gay, MA .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :931-938
[15]   Calcium Pyrophosphate Deposition Disease [J].
Rosenthal, Ann K. ;
Ryan, Lawrence M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26) :2575-2584
[16]   Comorbidities in Patients with Crystal Diseases and Hyperuricemia [J].
Sattui, Sebastian E. ;
Singh, Jasvinder A. ;
Gaffo, Angelo L. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40 (02) :251-+
[17]   Inflammation and Cardiovascular Diseases: The Most Recent Findings [J].
Sorriento, Daniela ;
Iaccarino, Guido .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
[18]  
Stainsby Brynne E, 2017, J Can Chiropr Assoc, V61, P40
[19]  
Virani SS, 2021, CIRCULATION, V143, pe254, DOI DOI 10.1161/CIR.0000000000000950
[20]   Erythrocyte sedimentation rate as a marker for coronary heart disease [J].
Yayan, Josef .
VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 :219-223